Chaitanya Pabbati
Psychiatry · San Diego, CANPI 1710237391
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 333 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 20.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,553, 2.4 times the $660 reported in 2019. Among psychiatry clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 333 payments — averaging $22.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- Otsuka America Pharmaceutical, Inc.$1K
- Lundbeck LLC$757
- AbbVie$727
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$574
- Takeda Pharmaceuticals U.S.A., Inc.$568
- plus $2K from 21 others
What the payments were for
- Food & beverage$7,32999%
- Education$981%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 64 | $1,535 |
| Otsuka America Pharmaceutical, Inc. | 51 | $1,016 |
| Lundbeck LLC | 36 | $757 |
| AbbVie(2 entities) | 36 | $727 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 22 | $574 |
| Takeda Pharmaceuticals U.S.A., Inc. | 30 | $568 |
| Sunovion Pharmaceuticals Inc. | 15 | $334 |
| Neurocrine Biosciences, Inc. | 11 | $293 |
| Indivior Inc. | 9 | $216 |
| Vanda Pharmaceuticals Inc. | 13 | $202 |
| Tempus AI, Inc | 3 | $175 |
| Axsome Therapeutics, Inc. | 6 | $141 |
| Corium, LLC | 5 | $119 |
| Alkermes, Inc. | 5 | $110 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 4 | $98 |
| Janssen Scientific Affairs, LLC | 1 | $90 |
| Shire North American Group Inc | 4 | $77 |
| Supernus Pharmaceuticals, Inc. | 4 | $76 |
| Brainsway USA Inc | 1 | $54 |
| Livanova USA, Inc. | 2 | $45 |
| Tris Pharma Inc | 2 | $45 |
| Alfasigma USA, Inc. | 2 | $43 |
| Merck | 2 | $43 |
| Ironshore Pharmaceuticals Inc. | 2 | $38 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Bausch Health US, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$120
How this compares
$7,427 in reported general payments places this provider in the 90th percentile of 4,954 psychiatry providers in California.
Other psychiatry in San Diego
- Jonathan MeyerSan Diego$2.3M
- Sanjai RaoSan Diego$445K
- Murray SteinSan Diego$121K
- Gustavo AlvaOrange$5.8M
- John KooSan Francisco$3M
- Jason KelloggIrvine$2.7M
- Charles Tuan-Tu NguyenIrvine$2.1M
- Manoj WaikarLos Gatos$1.9M
- Gerald MaguireSan Juan Capistraco$1.8M
- Salima BrillmanSunnyvale$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.